Cerbios-Pharma

Cerbios-Pharma SA is a privately held company based in Barbengo-Lugano, Switzerland, specialising in the development and manufacture of chemical and biological active pharmaceutical ingredients (APIs).

With a legacy spanning nearly five decades, Cerbios-Pharma SA has established itself as a leader in the pharmaceutical industry. The company offers exclusive contract development and manufacturing organisation (CDMO) services for high-potency APIs (HPAPIs), recombinant proteins, and antibody-drug conjugates (ADCs), supporting partners from preclinical stages through to commercial supply. Cerbios is committed to providing excellent services that assist partners in achieving their core business objectives, underpinned by a sustainable strategy that balances financial, social, and environmental value creation.

Key Products and Services

High-Potency Active Pharmaceutical Ingredients (HPAPIs): Cerbios offers development and manufacturing services for HPAPIs, including cytotoxic payloads used in ADCs. The company has expanded its manufacturing capacity with a new plant featuring reactors up to 1000 litres and pressure-filter-dryers, complementing existing HPAPI facilities.

Antibody-Drug Conjugates (ADCs): Cerbios is recognised as a front-runner in the development and manufacturing of ADCs, providing a unique advantage by developing and manufacturing ADC components—such as monoclonal antibodies (mAbs), toxins/payloads, and conjugates—on a single site in Lugano. This integrated approach enhances speed and quality in drug substance production.

Proteins and Antibodies: The company offers custom programmes for recombinant therapeutic proteins, from cloning to cGMP production. Utilising a proprietary CHO-K1 cell line and vector, Cerbios ensures high process productivity and quality, supporting clients in reducing development timelines for clinical trials and commercial supply.

Live Biotherapeutics: With over four decades of experience, Cerbios is a leading manufacturer of biopharmaceutical active ingredients, such as living bacteria, adhering to strict GMP quality standards. The company produces SF68®, a proprietary probiotic active ingredient, to cGMP pharmaceutical grade since 1978, and offers expertise in manufacturing probiotics and live biotherapeutics for global customers.

Chemical and Biological Competencies: Cerbios possesses extensive expertise in chemical and biological processes, including the development and manufacturing of living microorganisms. The company has been active in this field since 1976 and is considered a leading manufacturer of such products for pharmaceutical, food, and feed applications worldwide.

Cerbios-Pharma SA's dedication to innovation, quality, and sustainability has solidified its position as a trusted partner in the pharmaceutical industry. By offering a comprehensive range of products and services, the company continues to support its partners in achieving their business objectives while contributing positively to global health outcomes.